Both V(D)J coding ends but neither signal end can recombine at the bcl-2 major breakpoint region, and the rejoining is ligase IV dependent.

in Molecular and cellular biology by Sathees C Raghavan, Chih-Lin Hsieh, Michael R Lieber

TLDR

  • The study looked at how a common type of cancer called follicular lymphoma happens. It found that a specific part of the chromosome called the bcl-2 major breakpoint region (Mbr) is involved in this cancer. The study used tiny pieces of DNA to recreate the cancer and study how the pieces of DNA recombine. The results showed that the recombination happens in a specific way and that a certain protein called DNA ligase IV is important for it to happen. This information could help doctors find new ways to treat this type of cancer.

Abstract

The t(14;18) chromosomal translocation is the most common translocation in human cancer, and it occurs in all follicular lymphomas. The 150-bp bcl-2 major breakpoint region (Mbr) on chromosome 18 is a fragile site, because it adopts a non-B DNA conformation that can be cleaved by the RAG complex. The non-B DNA structure and the chromosomal translocation can be recapitulated on intracellular human minichromosomes where immunoglobulin 12- and 23-signals are positioned downstream of the bcl-2 Mbr. Here we show that either of the two coding ends in these V(D)J recombination reactions can recombine with either of the two broken ends of the bcl-2 Mbr but that neither signal end can recombine with the Mbr. Moreover, we show that the rejoining is fully dependent on DNA ligase IV, indicating that the rejoining phase relies on the nonhomologous DNA end-joining pathway. These results permit us to formulate a complete model for the order and types of cleavage and rejoining events in the t(14;18) translocation.

Overview

  • The study focuses on the t(14;18) chromosomal translocation, the most common translocation in human cancer, and its occurrence in all follicular lymphomas. The study aims to understand the mechanism of this translocation and the role of the bcl-2 major breakpoint region (Mbr) in it. The methodology used involves recapitulating the translocation on intracellular human minichromosomes and studying the recombination reactions between the coding ends of the translocation and the broken ends of the bcl-2 Mbr. The primary objective is to formulate a complete model for the order and types of cleavage and rejoining events in the t(14;18) translocation.

Comparative Analysis & Findings

  • The study found that either of the two coding ends in the V(D)J recombination reactions can recombine with either of the two broken ends of the bcl-2 Mbr but that neither signal end can recombine with the Mbr. The rejoining is fully dependent on DNA ligase IV, indicating that the rejoining phase relies on the nonhomologous DNA end-joining pathway. These results provide a complete model for the order and types of cleavage and rejoining events in the t(14;18) translocation.

Implications and Future Directions

  • The study's findings provide a better understanding of the mechanism of the t(14;18) translocation and the role of the bcl-2 Mbr in it. The results also highlight the importance of the nonhomologous DNA end-joining pathway in the rejoining phase of the translocation. Future research could build on these findings to develop new therapies for follicular lymphoma or other cancers that involve chromosomal translocations. Limitations of the study include the use of intracellular human minichromosomes, which may not fully recapitulate the complexities of the translocation in vivo. Future research could also explore the role of other proteins or pathways in the translocation and their potential as therapeutic targets.
Read Full Article